Chinese researchers have developed a new type of implantable cranial nerve probe. The reporter learned from Changchun Institute of Applied Chemistry, Chinese Academy of Sciences that Zhang Qiang, a researcher at the institute, and his collaborators have developed a new type of implantable hydrogel neural probe to realize long-term stable monitoring of cranial nerve signals, precise regulation of neural circuits, and preliminary exploration in the application of diagnosis and treatment of severe brain diseases. Related research results were recently published in the international academic journal Advanced Materials. (Xinhua News Agency)Ping An, China: From January to November, the accumulated property insurance premium income was 292.3 billion yuan.Market news: Israel said that the IDF will stay on the Syrian side of Mount Hermon for several months.
A picture to understand the 2024 Central Economic Work Conference. (Xinhua News Agency)Pacific Securities: Goldwind Technology's performance is expected to achieve rapid growth, with the first "buy" rating. Pacific Securities Research Report pointed out that with the profit recovery of wind turbine business and the contribution of wind farm investment and development and wind power service business, Goldwind Technology's (002202.SZ) performance is expected to achieve rapid growth. The first coverage gives a "buy" rating. Goldwind Technology has ranked first in the domestic wind power market for 13 consecutive years since 2011; However, in recent years, under the strong competitive pressure of wind turbine enterprises after the second line, their market share has declined. In the future, with the increase of market concentration, Goldwind Technology, as a leader, is expected to increase its share. At the end of the third quarter of 2024, the company's external order volume was 41.38GW, and sufficient in-hand order volume supported its share increase.The financial technology companies supported by Wal-Mart are valued at $2.5 billion. The traditional banking industry is under threat. Wal-Mart is injecting more funds into its newly-started financial start-ups, obtaining a valuation of $2.5 billion for this company, and indicating its ambition to further set foot in the financial services industry. According to informed sources, the world's largest retailer is jointly leading the financing of more than 300 million US dollars with investment company Ribbit Capital. This marks a new valuation for the company named One, in which Wal-Mart holds a majority stake. Wal-Mart has been providing products to many customers and employees in order to gain a greater foothold in the field of financial services. For the financial industry, the threat of Wal-Mart and other companies encroaching on its territory is getting closer and closer. Just last year, JPMorgan Chase CEO Jamie Dimon mentioned the competitive threat of Wal-Mart and other enterprises, pointing out that its hundreds of millions of customers and huge resources at its disposal were "extraordinary competitive advantages".
Borui Medicine: Carboprost injection is planned to win the bid for the national centralized drug procurement. Borui Medicine announced that in the tenth batch of national centralized drug procurement in which Borui Pharmaceutical, a wholly-owned subsidiary, participated, carboprost tromethamine injection is planned to win the bid. This product is mainly used for 13-20 weeks pregnant abortion and postpartum hemorrhage. The specification is 1 ml: 250μ g, and the proposed bid price is 16.96 yuan/piece. In the first year, the agreed purchase base is 220,400 pieces, which are mainly supplied to Henan, Hubei, Guangxi, Shaanxi, Gansu, Ningxia and other provinces. If the contract is finally selected and signed, it will help the product to quickly open the domestic market and enhance the market share and brand influence of the company. The product obtained the drug registration certificate in March 2024, and has not yet generated sales revenue.According to the weekly comprehensive price quotation and transaction information of the national carbon market, the comprehensive price quotation of the national carbon market this week is: the highest price is 102.03 yuan/ton, and the lowest price is 98.95 yuan/ton, and the closing price is 0.20% lower than last Friday. This week, the transaction volume of the listing agreement was 4,455,200 tons, with a turnover of 443,893,910.63 yuan; The volume of bulk agreement transactions was 35,748,795 tons, with a turnover of 353,449,4051.32 yuan. This week, the total turnover of the national carbon emission quota was 40,203,995 tons, with a total turnover of 397,877,961.95 yuan. From January 1 to December 13, 2024, the volume of carbon emission quota in the national carbon market was 169,736,665 tons, with a turnover of 162,864,7748.47 yuan. As of December 13, 2024, the cumulative turnover of carbon emission quotas in the national carbon market was 611,359,276 tons, with a cumulative turnover of 412,056,282,67.75 yuan. (National Carbon Trading)Singapore Straits Times Index closed at 3,810.35.
Strategy guide 12-13
Strategy guide
12-13
Strategy guide 12-13
Strategy guide 12-13
Strategy guide 12-13
Strategy guide 12-13
Strategy guide
12-13
Strategy guide 12-13